Aptevo Therapeutics Inc. (APVO) Gross margin 2016–2019
Aptevo Therapeutics Inc. (APVO) gross margin by fiscal year — reported gross profit divided by reported revenue.
13.6%FY2019 · since FY2016: 62.9% → 13.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | 13.6% | -9.9 pp |
| FY2018 | 23.5% | -26.3 pp |
| FY2017 | 49.8% | -13.1 pp |
| FY2016 | 62.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More APVO financial trends
APVO RevenueAPVO Net incomeAPVO Net marginAPVO Gross profitAPVO Operating incomeAPVO Operating marginAPVO Operating cash flowAPVO Free cash flowAPVO Capital expendituresAPVO Return on equityAPVO Stock buybacksAPVO Dividends paidAPVO Total assetsAPVO Total liabilitiesAPVO Shareholders’ equityAPVO overview →